|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 45/06 | |||
| A61K 31/4178 | |||
| A61K 31/454 | |||
| A61K 31/337 | |||
| A61K 35/00 | |||
| A61K 47/64 | |||
| A61K 47/69 |
| (11) | Number of the document | 3179990 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15756742.1 |
| Date of filing the European patent application | 2015-08-14 | |
| (97) | Date of publication of the European application | 2017-06-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/045244 |
| Date | 2015-08-14 |
| (87) | Number | WO 2016/025816 |
| Date | 2016-02-18 |
| (30) | Number | Date | Country code |
| 201462038113 P | 2014-08-15 | US |
| (72) |
HEUER, Timothy Sean, US
|
| (73) |
Sagimet Biosciences Inc.,
155 Bovet Rd 303, San Mateo, CA 94402,
US
|
| (54) | FATTY ACID SYNTHASE INHIBITOR FOR USE IN THE TREATMENT OF DRUG RESISTANT CANCER |
| FATTY ACID SYNTHASE INHIBITOR FOR USE IN THE TREATMENT OF DRUG RESISTANT CANCER |